The page lists 17 projects related to the topic "estrogen".
# | |||
---|---|---|---|
1 | EpiPredict | Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome | 2015 |
2 | OCN4OS | Organo-Catalytic Nanoparticles for Organic Synthesis | 2015 |
3 | breast cancer dormancy | Molecular characterisation of a clinical model of estrogen receptor-positive breast cancer dormancy | 2015 |
4 | EVOLPREG | Origination of novel gene regulatory networks in the evolution of mammalian pregnancy | 2016 |
5 | NeuroEE | Delineation of a brain circuit regulating energy expenditure to impact body weight | 2016 |
6 | ER_disease | Defining hormonal cross-talk and the role of mutations in estrogen receptor positive breast cancer | 2015 |
7 | GENDER-CF | Gender-related differences in expression of microRNAs in cystic fibrosis | 2017 |
8 | TaGFrag | Stabilising Protein-Protein Interactions: A Target-Guided Fragment-Based Approach | 2016 |
9 | MESI-STRAT | Systems Medicine of Metabolic-Signaling Networks: A New Concept for Breast Cancer Patient Stratification | 2018 |
10 | TAMYOCAL | Tamoxifen mediated protection on X-linked centronuclear myopathy: a mechanistic and pre-clinical study | 2018 |
11 | SMARTRIOX | Disruptive targeted drug delivery system via synergistic combination of intelligent DNA molecular machines and gated mesoporous nanoparticles | 2018 |
12 | EOBRECA | Differential Roles of Estrogens in Obesity-mediated ER+ Breast Cancer Development | 2019 |
13 | PullEd-MS | Finding unknown endocrine disrupting compounds through target pull-down assay filtration, effect direct analysis and ultra-high resolution mass spectrometry for a comprehensive efficient workflow. | 2019 |
14 | MechanoGPER | Development of GPER agonists as a novel therapeutic option for pancreatic cancer | 2019 |
15 | SMART | StiMuli-responsive reActoRs for waTer purification | 2019 |
16 | EndoSolve | A novel medical device for the treatment of Endometriosis | 2021 |
17 | C.A.R.E. OA | Cross-linking Adenosine Receptors - Estrogen receptors for OA treatment | 2021 |